Pharmacielo Stock Today
| PCLO Stock | CAD 0.08 0.01 6.67% |
PerformanceVery Weak
| Odds Of DistressVery High
|
Pharmacielo is selling for under 0.08 as of the 17th of March 2025; that is 6.67 percent increase since the beginning of the trading day. The stock's lowest day price was 0.08. Pharmacielo has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 17th of December 2024 and ending today, the 17th of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
PharmaCielo Ltd., through its subsidiary, PharmaCielo Colombia Holdings S.A.S., cultivates, processes, produces, and supplies medicinal-grade cannabis oil extracts and related products in Colombia and internationally. The company was formerly known as Pan American Cannabis Inc. The company has 182 M outstanding shares of which 46.14 K shares are at this time shorted by private and institutional investors with about 0.83 days to cover all short positions. More on Pharmacielo
Moving together with Pharmacielo Stock
Moving against Pharmacielo Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Pharmacielo Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Pharmacielo's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Pharmacielo or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman CEO | MSc MBA | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Drug Manufacturers - Specialty & Generic, Healthcare (View all Sectors) | ||||
Pharmacielo's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Pharmacielo's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsPharmacielo can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Pharmacielo's financial leverage. It provides some insight into what part of Pharmacielo's total assets is financed by creditors.
| |||||
Pharmacielo (PCLO) is traded on TSX Venture Exchange in Canada and employs 7 people. Pharmacielo is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 14.56 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pharmacielo's market, we take the total number of its shares issued and multiply it by Pharmacielo's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Pharmacielo operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 182 M outstanding shares of which 46.14 K shares are at this time shorted by private and institutional investors with about 0.83 days to cover all short positions.
Pharmacielo has accumulated about 33.46 M in cash with (1.97 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.34, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Pharmacielo Probability Of Bankruptcy
Ownership AllocationPharmacielo owns a total of 182 Million outstanding shares. Pharmacielo holds 7.8 pct. of its outstanding shares held by insiders and 4.28 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Pharmacielo Ownership Details
Pharmacielo Risk Profiles
Although Pharmacielo's alpha and beta are two of the key measurements used to evaluate Pharmacielo's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 4.8 | |||
| Standard Deviation | 6.55 | |||
| Variance | 42.91 | |||
| Risk Adjusted Performance | (0.07) |
Pharmacielo Stock Against Markets
| PCLO | 6.67 |
| Compare Correlations |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Pharmacielo without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stock Screener Now
Stock ScreenerFind equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
| All Next | Launch Module |
Pharmacielo Corporate Management
Elected by the shareholders, the Pharmacielo's board of directors comprises two types of representatives: Pharmacielo inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pharmacielo. The board's role is to monitor Pharmacielo's management team and ensure that shareholders' interests are well served. Pharmacielo's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pharmacielo's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Andres Botero | Chief Officer | Profile | |
| William Petron | Pres CEO | Profile | |
| BSc CMA | CFO Director | Profile | |
| Alex Bruvels | Corporate Secretary | Profile | |
| Marcelo Durante | Global Development | Profile | |
| Decio Filho | Chief Officer | Profile |
Additional Tools for Pharmacielo Stock Analysis
When running Pharmacielo's price analysis, check to measure Pharmacielo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmacielo is operating at the current time. Most of Pharmacielo's value examination focuses on studying past and present price action to predict the probability of Pharmacielo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmacielo's price. Additionally, you may evaluate how the addition of Pharmacielo to your portfolios can decrease your overall portfolio volatility.